glp-1 news september 30 2025 obesity drug today sep Amgen Reshapes the Obesity Drug Market with Innovative MariTide The expanding landscape of GLP-1
Description
These agents have several practical benefits for patients including promotion of weight loss, fewer needlesticks, ease of administration, and lower risk of hypoglycemia
News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s
American Society of Plastic Surgeons
Establishing a consistent sleep routine can help manage weight
The survey finding is no surprise: GLP-1s work by mimicking a hormone produced in the gut to suppress a person's appetite and regulate blood sugar
